These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
554 related articles for article (PubMed ID: 16138341)
1. Association between adverse pregnancy outcomes and maternal factor V G1691A (Leiden) and prothrombin G20210A genotypes in women with a history of recurrent idiopathic miscarriages. Mahjoub T; Mtiraoui N; Tamim H; Hizem S; Finan RR; Nsiri B; Almawi WY Am J Hematol; 2005 Sep; 80(1):12-9. PubMed ID: 16138341 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population. Finan RR; Tamim H; Ameen G; Sharida HE; Rashid M; Almawi WY Am J Hematol; 2002 Dec; 71(4):300-5. PubMed ID: 12447960 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of antiphospholipid antibodies, factor V G1691A (Leiden) and prothrombin G20210A mutations in early and late recurrent pregnancy loss. Mtiraoui N; Borgi L; Hizem S; Nsiri B; Finan RR; Gris JC; Almawi WY; Mahjoub T Eur J Obstet Gynecol Reprod Biol; 2005 Apr; 119(2):164-70. PubMed ID: 15808373 [TBL] [Abstract][Full Text] [Related]
4. Factor V Leiden and G20210A prothrombin mutations in patients with recurrent pregnancy loss: data from the southeast of Turkey. Altintas A; Pasa S; Akdeniz N; Cil T; Yurt M; Ayyildiz O; Batun S; Isi H Ann Hematol; 2007 Oct; 86(10):727-31. PubMed ID: 17572893 [TBL] [Abstract][Full Text] [Related]
5. Factor V G1691A (Leiden) and prothrombin G20210A single-nucleotide polymorphisms in type 2 diabetes mellitus. Wakim-Ghorayeb SF; Keleshian SH; Timson G; Finan RR; Najm P; Irani-Hakime N; Almawi WY Am J Hematol; 2005 Sep; 80(1):84-6. PubMed ID: 16138347 [TBL] [Abstract][Full Text] [Related]
6. [Genetic thrombophilic defects (Factor V Leiden, prothrombin G20210A, MTHFR C677T) in women with recurrent fetal loss]. Kovacheva K; Ivanov P; Konova E; Simeonova M; Komsa-Penkova R Akush Ginekol (Sofiia); 2007; 46(7):10-6. PubMed ID: 18333414 [TBL] [Abstract][Full Text] [Related]
7. Factor V Leiden G1691A and factor II G20210A point mutations and pregnancy in North-West of Iran. Bagheri M; Rad IA; Nanbakhsh F Arch Gynecol Obstet; 2011 Nov; 284(5):1311-5. PubMed ID: 21773779 [TBL] [Abstract][Full Text] [Related]
8. Distinct association of factor V-Leiden and prothrombin G20210A mutations with deep venous thrombosis in Tunisia and Lebanon. Bouaziz-Borgi L; Almawi WY; Mtiraoui N; Nsiri B; Keleshian SH; Kreidy R; Louzir B; Hezard N; Mahjoub T Am J Hematol; 2006 Aug; 81(8):641-3. PubMed ID: 16823828 [TBL] [Abstract][Full Text] [Related]
9. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives. Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134 [TBL] [Abstract][Full Text] [Related]
10. Association of factor V gene polymorphisms (Leiden; Cambridge; Hong Kong and HR2 haplotype) with recurrent idiopathic pregnancy loss in Tunisia. A case-control study. Zammiti W; Mtiraoui N; Mercier E; Abboud N; Saidi S; Mahjoub T; Almawi WY; Gris JC Thromb Haemost; 2006 Apr; 95(4):612-7. PubMed ID: 16601830 [TBL] [Abstract][Full Text] [Related]
11. Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations. DeSancho MT; Berlus N; Christos PJ; Rand J Blood Coagul Fibrinolysis; 2010 Jan; 21(1):11-5. PubMed ID: 19474699 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of factor V G1691A (Leiden) and prothrombin G20210A polymorphisms among apparently healthy Jordanians. Nusier MK; Radaideh AM; Ababneh NA; Qaqish BM; Alzoubi R; Khader Y; Mersa JY; Irshaid NM; El-Khateeb M Neuro Endocrinol Lett; 2007 Oct; 28(5):699-703. PubMed ID: 17984931 [TBL] [Abstract][Full Text] [Related]
13. The frequency of factor V Leiden and concomitance of factor V Leiden with prothrombin G20210A mutation and methylene tetrahydrofolate reductase C677T gene mutation in healthy population of Denizli, Aegean region of Turkey. Kabukcu S; Keskin N; Keskin A; Atalay E Clin Appl Thromb Hemost; 2007 Apr; 13(2):166-71. PubMed ID: 17456626 [TBL] [Abstract][Full Text] [Related]
14. Should factor V Leiden mutation and prothrombin gene polymorphism testing be done in women with recurrent miscarriage from North India? Parveen F; Shukla A; Agrawal S Arch Gynecol Obstet; 2013 Feb; 287(2):375-81. PubMed ID: 22990475 [TBL] [Abstract][Full Text] [Related]
15. Probability of recurrence of thrombosis in patients with and without factor V Leiden. Rintelen C; Pabinger I; Knöbl P; Lechner K; Mannhalter C Thromb Haemost; 1996 Feb; 75(2):229-32. PubMed ID: 8815565 [TBL] [Abstract][Full Text] [Related]
17. [Prothrombotic gene mutations in women with recurrent abortions and intrauterine fetal death]. Santoro R; Iannaccaro P; Sottilotta G Minerva Ginecol; 2005 Aug; 57(4):447-50. PubMed ID: 16170289 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening. Fábregues F; Tàssies D; Reverter JC; Carmona F; Ordinas A; Balasch J Fertil Steril; 2004 Apr; 81(4):989-95. PubMed ID: 15066453 [TBL] [Abstract][Full Text] [Related]
19. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis. Almawi WY; Tamim H; Kreidy R; Timson G; Rahal E; Nabulsi M; Finan RR; Irani-Hakime N J Thromb Thrombolysis; 2005 Jun; 19(3):189-96. PubMed ID: 16082606 [TBL] [Abstract][Full Text] [Related]
20. MTHFR C677T Polymorphism and factor V Leiden mutation are not associated with recurrent spontaneous abortion of unexplained etiology in Japanese women. Kobashi G; Kato EH; Morikawa M; Shimada S; Ohta K; Fujimoto S; Minakami H; Yamada H Semin Thromb Hemost; 2005 Jun; 31(3):266-71. PubMed ID: 16052395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]